Experiences of the REACH Testing Proposals System to Reduce Animal Testing

被引:0
|
作者
Taylor, Katy [1 ]
Stengel, Wolfgang [1 ]
Casalegno, Carlotta [1 ]
Andrew, David [2 ]
机构
[1] ECEAE, London N7 8NN, England
[2] TSGE Consulting Ltd, Knaresborough, England
关键词
REACH; alternatives; testing strategies; 3Rs; chemical safety; VITRO EMBRYOTOXICITY TESTS; REPRODUCTIVE TOXICITY; VALIDATION; PERFORMANCE; LEGISLATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to reduce animal testing, companies registering chemical substances under the EU REACH legislation must propose rather than conduct certain tests on animals. Third parties can submit "scientifically valid information" relevant to these proposals to the Agency responsible, the European Chemicals Agency (ECHA), who are obliged to take the information into account. The European Coalition to End Animal Experiments (ECEAE) provided comments on nearly half of the 817 proposals for vertebrate tests on 480 substances published for comment for the first REACH deadline (between August 1, 2009 and July 31, 2012). This paper summarizes the response by registrants and the Agency to third party comments and highlights issues with the use of read-across, in vitro tests, QSAR, and weight of evidence approaches. Use of existing data and evidence that testing is legally or scientifically unjustified remain the most successful comments for third parties to submit. There is a worrying conservatism within the Agency regarding the acceptance of alternative approaches and examples of where registrants have also failed to maximize opportunities to avoid testing.
引用
收藏
页码:107 / 128
页数:22
相关论文
共 50 条
  • [32] Toxicological databases: modern tools to reduce, refine and replace animal testing
    Schroeder, Katrin
    Simetska, Nelly
    Escher, Sylvia
    Mangelsdorf, Inge
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S87 - S88
  • [33] In vitro and integrated in vivo strategies to reduce animal use in genotoxicity testing
    Groff, Katherine
    Evans, Stephen J.
    Doak, Shareen H.
    Pfuhler, Stefan
    Corvi, Raffaella
    Saunders, Samantha
    Stoddart, Gilly
    MUTAGENESIS, 2021, 36 (06) : 389 - 400
  • [34] Application of the consistency approach to reduce animal use in vaccine potency testing
    Kulpa-Eddy, Jodie
    Dusek, David
    INTERNATIONAL WORKSHOP ON ALTERNATIVE METHODS TO REDUCE, REFINE, AND REPLACE THE USE OF ANIMALS IN VACCINE POTENCY AND SAFETY TESTING: STATE OF THE SCIENCE AND FUTURE DIRECTIONS, 2011, 5 : 232 - 235
  • [35] QSAR could reduce REACH animal tests
    Wood, J
    CHEMISTRY & INDUSTRY, 2004, (17) : 6 - 6
  • [36] Utilizing Design of Experiments to Reduce IT System Testing Cost
    Phadke, Madhav S.
    Phadke, Kedar M.
    2020 ANNUAL RELIABILITY AND MAINTAINABILITY SYMPOSIUM (RAMS 2020), 2020,
  • [37] Utilizing Design of Experiments to Reduce IT System Testing Cost
    Phadke, Madhav S.
    Phadke, Kedar M.
    2014 60TH ANNUAL RELIABILITY AND MAINTAINABILITY SYMPOSIUM (RAMS), 2014,
  • [38] Local Tolerance Testing Under REACH: Accepted Non-animal Methods Are Not on Equal Footing with Animal Tests
    Sauer, Ursula G.
    Hill, Erin H.
    Curren, Rodger D.
    Kolle, Susanne N.
    Teubner, Wera
    Mehling, Annette
    Landsiedel, Robert
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2016, 44 (03): : 281 - 299
  • [39] Stem Cell Testing as an alternative to animal testing
    Haneveld, Johan Klein
    TIJDSCHRIFT VOOR DIERGENEESKUNDE, 2015, 140 (11) : 32 - 33